Morepen Laboratories (NSE:MOREPENLAB) ROCE % : 22.33% (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Morepen Laboratories ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Morepen Laboratories's annualized ROCE % for the quarter that ended in Dec. 2023 was 22.33%.

Morepen Laboratories ROCE % Historical Data

The historical data trend for Morepen Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Morepen Laboratories ROCE % Chart

Morepen Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

11.80

13.81

26.05

24.18

8.23

Morepen Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															7.54	5.93	10.54	14.08	22.33

Morepen Laboratories ROCE % Calculation

Morepen Laboratories's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	577.361	/	( ( (10700.527 - 4564.569)	+	(11104.951 - 3211.631) )	/ 2 )
	=	577.361	/	( (6135.958	+	7893.32)	/ 2 )
	=	577.361	/	7014.639
	=	8.23 %

Morepen Laboratories's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	1847.68	/	( ( (11937.817 - 3662.059)	+	(0 - 0) )	/ 1 )
	=	1847.68	/	( ( 8275.758	+	0 )	/ 1 )
	=	1847.68	/	8275.758
	=	22.33 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Morepen Laboratories (NSE:MOREPENLAB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Morepen Laboratories ROCE % Related Terms

Thank you for viewing the detailed overview of Morepen Laboratories's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Morepen Laboratories (NSE:MOREPENLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Morepen Laboratories Ltd (NSE:MOREPENLAB) » Definitions » ROCE %

Traded in Other Exchanges

500288:India

Address

2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector 20, Gurugram, HR, IND, 122016

Website

https://www.morepen.com

Morepen Laboratories Ltd is an India based pharmaceutical company. It develops, manufactures and markets generic drugs and pharmaceutical formulations. The company's products includes Tablets, Capsules, Injections, Ointments, Syrups, and Powders. It also offers products under brands Burnol, Lemolate and Fiber-X. The company's geographical markets include India, the United States and the rest of the world, with a majority of revenue being generated in India.

Morepen Laboratories (NSE:MOREPENLAB) Headlines

No Headlines